This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
This chapter uses the definition of survivor on the NCI website: “An individual is considered a cancer survivor from the time of diagnosis, through the balance of his or her life. Family members, friends, and caregivers are also impacted by the survivorship experience and are therefore included in this definition. Adapted from the National Coalition for Cancer Survivorship. http://cancercontrol.cancer.gov/ocs/definitions.html.
CBTRUS. Statistical Report: Primary Brain Tumors in the United States, 1998–2002. Published by the Central Brain Tumor Registry of the United States, 2005.
CBTRUS (2005). Statistical Report: Primary Brain Tumors in the United States, 1998–2002. Published by the Central Brain Tumor Registry of the United States.
While some brain tumors can be benign or slow growing, all are neoplasia and can be disabling. “Cancer” is used here to apply to all types of brain tumors.
Epstein S. Impure Science: AIDS,Activism,and the Politics of Knowledge. Berkeley, CA: University of California Press, 1996.
Effective Lobbying Increases U.S. Funds for Breast Cancer Research. New York Times, October 19, 1992.
Clark E, Stovall E. Advocacy: the cornerstone of cancer survivorship. Cancer Pract. 1996;4(5):239–244.
Weiner SL, McCabe MS, Smith G, Monaco GP, Fiduccia D. Pediatric cancer: Advocacy, legal, insurance and employment Issues. In: Pizzo P, and Poplack D, eds. Principles and Practice of Pediatric Oncology, 4th ed. Philadelphia: Lippincott Raven Publishers, 2001.
Hoffman B, Stovall E. Survivorship perspectives and advocacy. J Clin Oncol. 2006;24:5154–5159.
For example, the American Brain Tumor Association, http://www.abta.org, the National Brain Tumor Foundation, http://www.braintumor.org, and the Children’s Brain Tumor Foundation, http://www.cbtf.org.
National Cancer Institute 2006 Fact Book, http://obf.cancer.gov/financial/attachments/06Factbk.pdf.
Personal communication, Brain Tumor Funders’ Collaborative.
See for example, the Sontag Foundation at http://www.sontagfoundation.org
American Brain Tumor Association and Pediatric Brain Tumor Foundation of the US.
http://abta.org/index.cfm?contentid=38 http://www.braintumor.org.http://www.sontagfoundation.org.
Institute of Medicine, Committee on the NIH Research Priority-Setting Process, Scientific Opportunities and Public Needs: Improving Priority Setting and Public Input at the National Institutes of Health, 1998.
North American Brain Tumor Consortium and New Approached to Brain Tumor Therapy (which at this writing are merging) and Pediatric Brain Tumor Consortium.
Acknowledgments
The authors would like to thank Elizabeth Goss, long-time policy counsel to NABTC, for her substantive contributions and commitment to advocacy for brain tumor patients, survivors and families.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Weiner, S.L., Lustig, C. (2009). Pathways to Brain Tumor Advocacy. In: Goldman, S., Turner, C. (eds) Late Effects of Treatment for Brain Tumors. Cancer Treatment and Research, vol 150. Springer, Boston, MA. https://doi.org/10.1007/b109924_25
Download citation
DOI: https://doi.org/10.1007/b109924_25
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-77102-1
Online ISBN: 978-0-387-77103-8
eBook Packages: MedicineMedicine (R0)